Cocrystal Pharma, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cocrystal Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Cocrystal Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$4.94M, a 18.6% decline year-over-year.
  • Cocrystal Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$18.7M, a 3.78% decline year-over-year.
  • Cocrystal Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$18M, a 53.7% increase from 2022.
  • Cocrystal Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$38.8M, a 174% decline from 2021.
  • Cocrystal Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$14.2M, a 47% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$18M +$20.9M +53.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 -$38.8M -$24.7M -174% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$14.2M -$4.54M -47% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 -$9.65M +$38.5M +80% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 -$48.2M +$879K +1.79% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-17
2018 -$49M -$48.4M -7901% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 -$613K +$74.3M +99.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$74.9M -$24.8M -49.4% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-21
2015 -$50.1M -$50M -50528% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-21
2014 -$99K +$3.79M +97.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-31
2013 -$3.89M +$4.08M +51.2% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 -$7.96M -$2.51M -45.9% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
2011 -$5.46M -$5.14M -1606% Jan 1, 2011 Dec 31, 2011 10-K 2013-04-01
2010 -$320K Jan 1, 2010 Dec 31, 2010 10-K 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.